Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome

Prenatal Diagnosis

Volumn 29, Issue 8, 2009, Pages 814-815

  Sermondade, Nathalie ^a   Dreux, Sophie ^a   Oury, Jean François ^a   Muller, Françoise ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Foetal and placental pathology; Foetal therapy; HCG; Maternal serum screening; Monochorionic twins; Twin to twin transfusion syndrome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; FETUS; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; TWIN PREGNANCY; TWIN TWIN TRANSFUSION SYNDROME;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; FETOFETAL TRANSFUSION; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 67749140026     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2285     Document Type: Article

References (10)

1. Benn PA, Egan JFX, Ingardia CJ. 2002. Extreme second-trimester serum analyte values in Down syndrome pregnancies with hydrops fetalis. J Matern Fetal Neonatal Med 11: 262-265.
2. Benn PA, Ying J. 2004. Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45X caryotype using AFP and unconjugated estriol and hCG. J Matern Fetal Neonatal Med 15: 160-166.
3. Cuckle HS. 2000. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92: 97-102.
4. Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM. 2000. Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. Am J Obstet Gynecol 182: 417-426. (Pubitemid 30127357)
5. Garchet-Beaudron A, Dreux S, Leporrier N, Oury JF, Muller F, ABA Study Group, Clinical Study Group. 2008. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies. Prenat Diagn 28: 1105-1109.
6. Mahieu-Caputo D, Salomon LJ, Le Bidois J, et al. 2003. Fetal hypertension: an insight into the pathogenesis of the twin-twin transfusion syndrome. Prenat Diagn 23: 640-645. (Pubitemid 36987406)
7. Muller F, Dreux S, Dupoizat H, et al. 2003. Second-trimester Down syndrome maternal serum screening in.twin pregnancies: impact of chorionicity. Prenat Diagn 23: 331-335. (Pubitemid 36457270)
8. Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH. 1997. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 10: 86-89. (Pubitemid 27412245)
9. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. 2004. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 351: 136-144. (Pubitemid 38886648)
10. Wald NJ, Rish S. 2005. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies. Prenat Diagn 25: 740-745. (Pubitemid 41405941)